AU2001267527A1 - Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions - Google Patents

Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions

Info

Publication number
AU2001267527A1
AU2001267527A1 AU2001267527A AU6752701A AU2001267527A1 AU 2001267527 A1 AU2001267527 A1 AU 2001267527A1 AU 2001267527 A AU2001267527 A AU 2001267527A AU 6752701 A AU6752701 A AU 6752701A AU 2001267527 A1 AU2001267527 A1 AU 2001267527A1
Authority
AU
Australia
Prior art keywords
bordetella
pertactin
parapertussis
bronchiseptica
repeated regions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001267527A
Other languages
English (en)
Inventor
Caroline Boursaux-Eude
Nicole Guiso-Maclouf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Publication of AU2001267527A1 publication Critical patent/AU2001267527A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001267527A 2000-05-25 2001-05-23 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions Abandoned AU2001267527A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20696900P 2000-05-25 2000-05-25
US60/206,969 2000-05-25
PCT/EP2001/006457 WO2001090143A2 (en) 2000-05-25 2001-05-23 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions

Publications (1)

Publication Number Publication Date
AU2001267527A1 true AU2001267527A1 (en) 2001-12-03

Family

ID=22768696

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001267527A Abandoned AU2001267527A1 (en) 2000-05-25 2001-05-23 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions

Country Status (11)

Country Link
US (3) US7070779B2 (https=)
EP (1) EP1284993B1 (https=)
JP (1) JP2003533990A (https=)
AT (1) ATE393166T1 (https=)
AU (1) AU2001267527A1 (https=)
CY (1) CY1110430T1 (https=)
DE (1) DE60133734T2 (https=)
DK (1) DK1284993T3 (https=)
ES (1) ES2303833T3 (https=)
PT (1) PT1284993E (https=)
WO (1) WO2001090143A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (fr) * 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
ATE393166T1 (de) 2000-05-25 2008-05-15 Pasteur Institut Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen
EP2161035B1 (en) 2007-05-28 2019-08-21 Daiichi Sankyo Company, Limited Bordetella parapertussis-containing whole-cell vaccine composition
CU23679A1 (es) 2007-10-30 2011-07-11 Ct Ingenieria Genetica Biotech Variantes de pertactinas para uso vacunal
EP2430040A1 (en) * 2009-05-11 2012-03-21 Novartis AG Antigen purification process for pertactin antigen
US8261986B2 (en) * 2009-10-21 2012-09-11 Kevin Kwong-Tai Chung System and method for decoding an optically readable markable sheet and markable sheet therefor
RS61723B1 (sr) * 2011-02-04 2021-05-31 Zoetis Services Llc Imunogenične bordetella bronchiseptica kompozicije
KR20130112950A (ko) * 2011-02-04 2013-10-14 조에티스 엘엘씨 개 호흡기 복합 질환용 조성물
CN109879942A (zh) * 2019-03-01 2019-06-14 浙江省农业科学院 一种兔波氏杆菌外膜蛋白及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007416D0 (en) * 1990-04-02 1990-05-30 Wellcome Found Expression of heterologous protein in yeast
GB9027901D0 (en) * 1990-12-21 1991-02-13 Wellcome Found Acellular vaccine
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
ATE393166T1 (de) * 2000-05-25 2008-05-15 Pasteur Institut Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen

Also Published As

Publication number Publication date
DE60133734T2 (de) 2009-05-14
CY1110430T1 (el) 2012-05-23
EP1284993B1 (en) 2008-04-23
PT1284993E (pt) 2008-06-11
US20060008474A1 (en) 2006-01-12
DK1284993T3 (da) 2008-07-28
US20040166116A9 (en) 2004-08-26
US6964767B2 (en) 2005-11-15
EP1284993A2 (en) 2003-02-26
US20030180307A1 (en) 2003-09-25
US7070779B2 (en) 2006-07-04
DE60133734D1 (de) 2008-06-05
JP2003533990A (ja) 2003-11-18
WO2001090143A3 (en) 2002-09-26
US7314910B2 (en) 2008-01-01
WO2001090143A2 (en) 2001-11-29
US20020192237A1 (en) 2002-12-19
ES2303833T3 (es) 2008-09-01
ATE393166T1 (de) 2008-05-15

Similar Documents

Publication Publication Date Title
MXPA03005222A (es) Derivado de metanosulfonamido-benzofurano, su procedimiento de preparacion y su utilizacion como intermediario de sisntesis.
MXPA02010826A (es) Compuestos y metodos para el tratamiento y la prevencion de infeccion bacteriana.
CY1110430T1 (el) Πολυπεπτιδια περιεχοντα πολυμορφισμους των επαναλαμβανομενων περιοχων της περτακτινης σε bordetella pertussis, bordetella paraperussis kai bordetella bronchiseptica. χρηση αυτων σε διαγνωστικες και ανοσογονες συνθεσεις
GEP20094675B (en) Heteroaryl- tetra-hydropiperidyl compounds useful for treating or preventing pain
BR0108058A (pt) Corpo maciço
NL300605I2 (https=)
HN2000000109A (es) Trifluorbutenos nematicidas
MY127718A (en) Dolastatin 10 derivatives.
MXPA03000612A (es) Metodos y procesos mejorados para desinfeccion con yodo.
MXPA03005601A (es) Nuevos compuestos y composiciones como inhibidores de catepsina.
AU2001266575A1 (en) Chemical compounds
DE50204688D1 (de) N-alkylaziridinoprepolymere als dentalmasse
WO2002094190A3 (en) Heterologous protection induced by immunization with invaplex vaccine
FI972054A0 (fi) Immunogeenisiä koostumuksia
WO2001074394A8 (en) New combination of a betablocker and a cholesterol-lowering agent
EP1762620A3 (en) Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
MEP5808A (xx) Ecitalopram bromhidrat i postupak za njegovo pripremanje
WO2002022150A3 (de) Arzneimittel enthaltend aktiviertes antithrombin iii
UY27373A1 (es) Formulaciones de interferón beta-humano
EP1303300A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS
AU5625796A (en) Protective epitopes of adenyl cyclase-haemolysin(AC-Hly), their application to the treatment or to the prevention of bordetella infections
MXPA02012015A (es) Ligandos de receptores para integrinas.
PT863981E (pt) Detecção, prevenção e tratamento de dermatite digital papilomatosa
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
Chapman et al. Silence at Ramscliffe